Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets

摘要

599172 Disclosed herein is the use of CXCR1 and/or CXCR2 inhibitors for the preparation of a medicament for use as an adjuvant in the transplant of pancreatic islets in Type 1 diabetes patients. In particular, the compounds that can be used according to the invention have the following formula (I) in which R and R’are as defined in the description.